Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
To
OTC Journal Members:
 |
Comments
in the BLOG |
 |
I posted a comment in the BLOG
on Tuesday's edition on the history of polling in the Datascension section.
As several loyal followers pointed out, my statement on the results of
the 1960 Presidential election were simply wrong. Correction made, and
the stock is up 37% off last week's low.
To use the BLOG, simply go
to the home page at www.otcjournal.com
- the BLOG will scroll down automatically on the right side of your
screen. The most current journal entries appear in the middle of your screen.
Check back frequently for updates particularly when stocks are moving to
overbought or oversold levels or in volatile markets. Your questions and
postings do not automatically appear, so don't bother posting the same
question multiple times. I personally go through to moderate and respond
to every question.
 |
As August Arrives,
Sharks Should Be Circling |
|
August is flat out my favorite month
of the year to buy stocks with a three to six month time horizon. No one
is around, and no one is paying attention. Good microcaps tend to drift
down on light volume as there are typically a few small sellers around
and not many buyers.
In mid September the kids go back
to school and everybody gets back to work. Oversold stocks rebound on light
volume. The rebound attracts the "late to the party" gang, and you sit
around wondering why you didn't buy XXXX when it was really cheap in August.
Like a shark, you should be circling
for value and oversold situations. You should be hunting the weak to take
advantage of the bargains which vaporize as soon as business returns to
normal.
I have often admired the Italians.
After all, they have some of the best art, music, wine, food, cars, and
clothes in the world. Yet, somehow they manage to virtually close the country
for the month of August. If it weren't for the American free enterprise
go-getter mentality, we would do the same. Sometimes I wonder if it wouldn't
be better for our national psyche.
I'm going to devote the remainder
of the year to some new ideas in heathcare/biotech. I believe this group
is getting ready to explode in September to December time frame. Now is
the time to uncover some great ideas for Santa profits.
The first idea will come out this
weekend. Here's a preview:
|
The
Best Sugar Substitute |
|
I'll be publishing some stats this
weekend on the obesity epidemic in the US. It's out of control, and processed
foods loaded with sugar and fat are the true culprit.
So- why don't food manufacturers
use a zero calorie zero carb sugar substitute in their products? Because
there isn't a good one.
Aspartame has been around
for ever, but it is chemical and leaves a bad aftertaste.
Splenda and Equal are
the new kids on the block. Splenda is synthesized out of the sugar molecule.
There have been some studies suggesting harmful side effects. You can't
bake with them. They don't blend very well. The version you see in the
stores for baking is simply half sugar, and therefore half the same problems.
There is a revolutionary new product
hitting the market as I write this edition. No calories, no carbs, no aftertaste,
tastes exactly like sugar, and bakes exactly like sugar in the same ratios.
It is 99.5% natural.
I've read one report projecting this
company will achieve $400 million in revenues within three years. You can
read about it on Saturday before the rest of the world knows. I'm going
to arrange for everyone who wants it to get a free sample. Try it yourself,
and let me know if you agree.
Here's the best part: The company
is on the verge of a major product roll out, but the stock is 43% lower
than the high set in February.
Since June 1 I have published four
profit alerts: XNOM, ZAPZ, TREN, and most recently GEPT.
That's a pretty sound track record in a normally weak time of the year.
Between now and the end of 2005 there
will be more. Stay tuned for the weekend edition. I know only about 1/2
the normal readership will be around, but those who are have a competitive
timing advantage.
|
Subscribe |
|
Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription.
Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.
To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best
way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable
email newsletter delivery.
Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.
|
